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Abstract
Background: Hospitalizations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
infection have increased in New York City, with substantial geographic variation across neighborhoods. While
individual-level risk factors, such as age, sex, HIV infection, and diabetes have been described, the role of
neighborhood-level factors (e.g., neighborhood HIV prevalence or income) has not been examined.
Methods: To explore plausible neighborhood-level factors associated with CA-MRSA-related hospitalizations, a
retrospective analysis was conducted using New York City hospital discharges from 2006 and New York City-specific
survey and health department surveillance data. CA-MRSA-related hospitalizations were identified using diagnosis
codes and admission information. Associations were determined by using sex-specific multilevel logistic regression.
Results: The CA-MRSA hospitalization rate varied by more than six-fold across New York City neighborhoods.
Females hospitalized with CA-MRSA had more than twice the odds of residing in neighborhoods in the highest
quintile of HIV prevalence (adjusted odds ratio [AOR]Q5 vs. Q1 2.3, 95% CI: 1.2, 2.7). Both males and females
hospitalized with CA-MRSA had nearly twice the odds of residing in neighborhoods with moderately high
proportion of men who have sex with men (MSM) residing in the neighborhood (males: AORQ4 vs. Q1 1.7, 95% CI: 1.1,
2.7; females: AORQ4 vs. Q1 2.0, 95% CI: 1.1, 3.6); but this association did not hold for neighborhoods in the highest
quintile (males: AORQ5 vs. Q1 1.2, 95% CI: 0.76, 1.8; females: AORQ5 vs. Q1 1.5, 95% CI: 0.82, 2.7).
Conclusions: Neighborhood-level characteristics were associated with CA-MRSA hospitalization odds, independent
of individual-level risk factors, and may contribute to the population-level burden of CA-MRSA infection.
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Background
Community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) has become a common cause of
morbidity in the United States and around the world
[1-3]. In 2006, the rate of hospitalization with CA-MRSA
in New York City was estimated to be 10.7 per 100,000
people [4], more than twice that of the US population
[5], and varied greatly across neighborhoods [4], raising
the possibility of neighborhood-level risk factors for CA-
MRSA.
Several individual-level factors have been found to be
associated with an increased risk of CA-MRSA infection,
including male sex [4,5], drug use [6], participation in
contact sports [7], sharing of personal items [8,9], and
homelessness [6,10]. Neighborhood-level or geographic
risk factors are correlated with individual-level factors,
but their role in CA-MRSA hospitalization has not been
systematically examined. Plausible neighborhood-level
risk factors for CA-MRSA include neighborhood HIV
prevalence and the proportion of men in the neighbor-
hood who are men who have sex with men (MSM), as
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rates of CA-MRSA are higher among HIV positive
persons [11,12] as well as MSM [13]; neighborhood in-
come distribution, as CA-MRSA risk factors including
crowding [14] and limited access to medical care [10]
may be more common among persons living in poverty;
and levels of emergency department (ED) usage [15], be-
cause persons lacking health insurance may rely on the
ED for medical treatment for worsening CA-MRSA
infections.
In order to evaluate the influence of neighborhood
factors on CA-MRSA hospitalizations among New York
City residents, we used a combination of data sources
and examined the multilevel associations between
neighborhood-level factors and individual odds of
CA-MRSA hospitalization relative to all other non-
Staphylococcus aureus hospitalizations, controlling for
measured individual-level risk factors. Understanding
neighborhood-level risk factors for CA-MRSA, as has
been done for a number of other health outcomes
[16-18], is important to help to target public health sur-
veillance and interventions for what has become an
increasing public health concern.
Methods
Study population
We examined data on all hospitalizations except those
related to births and those of children under 1 year of
age (assuming most were hospitalized for birth in the
past year) among New York City residents in 2006.
Neighborhood designations were based on aggregations
of zip codes into 42 New York City United Hospital
Fund (UHF) neighborhoods, ranging in population from
approximately 35,000 to 499,000 residents [19].
Definitions
Data on hospitalizations were drawn from the New York
Statewide Planning and Research Cooperative System
(SPARCS), an event-based dataset of hospital discharges
containing patient demographics, 15 diagnosis fields,
billing and address information [20]. Although data were
considered identified, they did not contain names, raw
birthdates, or street addresses. Patient zip code and UHF
neighborhood of residence were used in this analysis.
To identify MRSA hospitalizations, diagnosis fields
(principal and other) for each hospitalization in 2006
were evaluated using International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) codes. Hospitalizations with diagnosis codes for
Staphylococcus aureus pneumonia (482.41), Staphylococ-
cus aureus septicemia (038.11), or Staphylococcus aureus
infection specified elsewhere or unspecified (041.11),
and an additional ICD-9-CM (V09.0) indicating resist-
ance to drugs (in this case, methicillin) were considered
MRSA-related hospitalizations [4]. MRSA hospitalizations
were classified as CA-MRSA if discharge records indicated
the patient (1) had MRSA diagnosis on admission based
on a present-on-admission indicator; (2) had not been
transferred from another health care facility, including
nursing homes, long term care facilities and hospitals or
was admitted for complications from a surgical procedure;
(3) had not been hospitalized earlier in 2006; and (4) was
not diagnosed with a chronic condition that results in fre-
quent hospitalization including chronic renal failure, can-
cer, chronic obstructive pulmonary disease, or congestive
heart failure [4,21]. Other MRSA hospitalizations were
considered to be healthcare-associated (HA-MRSA).
Individual-level covariates
Age, sex, recorded diabetes diagnosis, and HIV-related
diagnoses were previously found to be associated with
CA-MRSA hospitalization in New York City [4] and
therefore were included in this analysis. Age was divided
into 4 categories: under 18, 18 to 44, 45 to 64, and 65
and greater years of age. Principal or secondary diagno-
sis codes, based on ICD-9-CM codes, were used to clas-
sify hospitalizations related to diabetes and a pre-existing
indicator based on ICD-9-CM codes and disease-related
groupings (DRGs) was used to identify HIV.
Neighborhood-level variables
HIV prevalence, the percentage of UHF neighborhood
residents living with HIV/AIDS, was estimated using the
number of persons diagnosed and living with HIV/AIDS
by UHF neighborhood provided by the Bureau of HIV/
AIDS at the New York City Department of Health and
Mental Hygiene (NYCDOHMH) [22] and New York
City UHF neighborhood population estimates [23].
MSM proportion, defined as the proportion of men who
report having sex with at least one man in the past year,
was based on survey data collected by the New York
City Community Health Survey, an annual random-digit
-dial survey of 10,000 residents [24]. Aggregate estimates
combining survey data from 2003 to 2006 were created
by the Bureau of Epidemiology Services at NYCDOHMH.
Data on neighborhood income came from the 2000 US
Census. Median household income for each zip code was
averaged to create UHF neighborhood estimates. The
number of emergency department visits by neighborhood
of residence [25] was provided by the Syndromic Surveil-
lance Unit at the NYCDOHMH and were converted to
UHF neighborhood rates (ED visits per 100,000 popula-
tion) based on New York City population estimates [23].
UHF neighborhood-level variables were divided into
quintiles for the purposes of statistical analyses.
Analysis
To examine differences in CA-MRSA rates across neigh-
borhoods, we mapped the 2006 CA-MRSA hospitalization
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rates by UHF neighborhood population. Mapping was
performed with ArcGIS 9. To determine the associations
between neighborhood-level characteristics and hospitaliza-
tion with CA-MRSA at the individual-level, we employed
multilevel modeling to compare characteristics of persons
hospitalized with CA-MRA were compared to those of
non-Staphylococcus hospitalizations. Multilevel modeling,
also known as hierarchical modeling, was necessary because
the data were organized at the neighborhood- and individual-
levels; the individuals were nested within neighborhoods. We
hypothesized neighborhood-level factors would be associated
with CA-MRSA hospitalization independent of measured
individual-level risk factors. To identify individual-level
factors associated with CA-MRSA hospitalization, we cons-
tructed sex-specific logistic regression models with only
individual-level factors. We then constructed similar models
including a single neighborhood level factor. Finally,
multilevel models that contained both individual-level factors
and a neighborhood-level factor were constructed to explore
sex-specific associations between neighborhood-level factors
and CA-MRSA hospitalizations, adjusting for individual-level
covariates. We report crude and adjusted odds ratios with
95% confidence intervals. To reduce the impact of possible
misclassification, HA-MRSA hospitalizations and hospita-
lizations with any other Staphylococcus diagnoses were
excluded from the analysis. Analyses were performed with
SAS 9.1.
SPARCS hospitalization data was obtained through a data
use agreement between the NYCDOHMH and SPARCS
Data Protection Review Board. This project was approved
by the NYCDOHMH Institutional Review Board as re-
search involving materials that have already been collected.
Results
Descriptive and crude analyses
Among New York City residents in 2006, there were 645
CA-MRSA hospitalizations and 908,184 non-Staphylococ-
cus hospitalizations. The CA-MRSA hospitalization rate
varied by more than six-fold across neighborhoods, ran-
ging from 3.0 to 18.3 per 100,000. Higher rates clustered
in certain areas, including the Bronx and some UHF
neighborhoods in Manhattan (Figure 1).
Sex-specific bivariate analysis of crude associations be-
tween individual-level age, diabetes diagnosis, and HIV
diagnosis are shown in Table 1. Among males, those
hospitalized with CA-MRSA tended to be younger, with
an odds ratio (OR) of 3.5 (95% CI 2.3, 5.2) for those
under 18, 4.0 (95% CI 3.0, 5.4) for those aged 18 to 44,
and 2.4 (95% CI 1.8, 3.3) for those aged 45 to 64, each
compared to 65 and older. Among females, CA-MRSA
hospitalizations were as likely to be 18 to 44 years old as
they were to be 65 and older (OR 1.1, 95% CI 0.75, 5.5).
CA-MRSA hospitalizations had more than 3 times the
odds of having an HIV diagnosis (males: OR 3.3, 95% CI
2.5, 4.3; females: OR 3.1, 95% CI: 1.9, 5.1). Having a dia-
betes diagnosis was significantly associated with CA-
MRSA hospitalization only among females (OR 1.4, 95%
CI 1.1, 1.9).
In crude sex-specific analyses including only neighbor-
hood HIV prevalence, those hospitalized with CA-MRSA
were significantly more likely to come from the highest
HIV prevalence neighborhoods in NYC compared with
those from the lowest prevalence neighborhoods for both
males (ORQ5 vs. Q1 1.7, 95% CI 1.0, 2.7) and females (OR Q5
vs. Q1 2.7, 95% CI 1.5-5.0). Males and females hospitalized
with CA-MRSA were also more likely to be from
neighborhoods with moderately high versus lower MSM
proportion (males: OR Q4 vs. Q1 1.9, 95% CI 1.2, 3.1;
females: OR Q4 vs. Q1 2.1, 95% CI 1.1, 3.9), but the associ-
ation did not hold at higher levels of neighborhood MSM
proportion. There was no significant crude association with
neighborhood income distribution or ED usage (Table 1).
Multivariable analysis
In multivariable logistic regression models, all individual-
level risk factors examined were statistically significantly
associated with CA-MRSA hospitalization. Individual-
level risk factors remained significant and of similar mag-
nitude with the inclusion of each neighborhood-level
characteristic in separate sex-specific multilevel models
except diabetes, which was not significant in the crude
model for hospitalized males but was significant in all
adjusted models (adjusted odds ratio (AOR) 1.3, 95% CI
1.0, 1.7) that included a neighborhood factor.
After adjusting for individual-level risk factors,
females hospitalized with CA-MRSA had more than
twice the odds of residing in UHF neighborhoods with
the highest HIV prevalence compared to the lowest
(AORQ4 vs. Q1 2.3, 95% CI 1.2, 2.7). Though adjusted
odds ratios at other levels of HIV prevalence were not
statistically significant, the odds of hospitalization with
CA-MRSA increased with increasing HIV prevalence.
There were no significant differences by neighborhood
HIV prevalence among males. In separate models, both
males and females hospitalized with CA-MRSA had
nearly twice the odds of residing in neighborhoods with
moderately high proportion of men who have sex
with men residing in the neighborhood (males:
AORQ4 vs. Q1 1.7, 95% CI: 1.1, 2.7; females: AORQ4 vs.
Q1 2.0, 95% CI: 1.1-3.6); but this association did not hold
for neighborhoods in the highest quintile proportion of
MSM (males: AORQ5 vs. Q1 1.2, 95% CI: 0.76, 1.8; females:
AORQ5 vs. Q1 1.5, 95% CI: 0.82-2.7). UHF neighborhood in-
come and ED usage rate were not significant predictors of
CA-MRSA hospitalization in multilevel analyses for males
or females (Table 2).
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Discussion
Our analyses suggest important, biologically plausible
neighborhood-level factors that may, in part, drive CA-
MRSA hospitalization rates at the population-level in New
York City. In sex-specific multilevel analyses, strong posi-
tive associations between higher UHF neighborhood HIV
prevalence and MSM proportion with higher odds of CA-
MRSA hospitalization persisted, even after controlling for
individual factors. Additionally, important differences in in-
dividual and neighborhood-level risk factors for CA-MRSA
hospitalization between males and females were observed.
Our analysis showed that neighborhood HIV prevalence
was associated with increased odds of CA-MRSA
hospitalization among females even after controlling for
individual HIV-status. While the associations between HIV
prevalence and odds of hospitalization with CA-MRSA
were not statistically significant at lower HIV prevalence
levels, a dose–response relationship is suggested. Studies,
including ours, have found HIV positive persons to be at an
increased risk for CA-MRSA infection and hospitalization
with CA-MRSA, possible due to increased viral load,
weakened immune systems, lack of antiretroviral therapy,
Figure 1 CA-MRSA hospitalization rate per 100,000 people, New York City neighborhoods, 2006.
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or problems with skin integrity [4,11,26,27]. This raises the
possibility that neighborhood HIV prevalence may play a
role in CA-MRSA transmission even among HIV-negative
persons, and that the attributable fraction of CA-MRSA
hospitalizations associated with HIV may be greater than
previously thought.
We also found higher neighborhood MSM proportion to
be associated with CA-MRSA hospitalization for both
males and females. While we did observe differences by
neighborhood MSM proportion at the extreme ends of the
distribution, we did not observe a dose–response relation-
ship and the association did not extend to neighborhoods
in the highest quintile of neighborhood MSM proportion.
A population-based study in San Francisco found that zip
codes with higher percentage of partnerships being same-
sex male also had higher rates of CA-MRSA infection [28].
Table 2 Adjusted odds ratios for associations between
neighborhood-level characteristics and hospitalizations
with CA-MRSA, controlling for individual-level
characteristics, New York City, 2006
Males Females
AOR 95% CI AOR 95% CI
HIV Prevalence
≤ 0.37% 1.0 - 1.0 -
0.38-0.73% 1.1 0.67, 1.7 1.5 0.84, 2.7
0.74%-1.3% 1.3 0.81, 2.2 1.7 0.90, 3.1
1.3-1.65% 1.2 0.73, 2.0 1.1 0.56, 2.1
> 1.65% 1.1 0.71, 1.9 2.3 1.2, 2.7
MSM Proportion
≤ 5.7% 1.0 - 1.0 -
5.8-7.0% 1.2 0.72, 1.9 1.9 1.0, 3.5
7.1-8.0% 1.3 0.86, 1.9 1.4 0.84, 2.5
8.1-9.8% 1.7 1.1, 2.7 2.0 1.1, 3.6
> 9.8% 1.2 0.76, 1.8 1.5 0.82, 2.7
Income per year ($)
≤ 26,000 0.94 0.64, 1.4 0.95 0.55, 1.6
26,001-35,000 0.76 0.49, 1.2 0.58 0.32, 1.1
35,000-41,000 1.3 0.85, 1.9 0.89 0.49, 1.6
41,000-48,000 0.69 0.45, 1.0 0.72 0.41, 1.3
> 48,000 1.0 - 1.0 -
ED Usage Rate*
≤ 24,000 1.0 - 1.0 -
24,001-32,600 0.63 0.40, 1.0 0.98 0.51, 1.9
32,601-44,200 0.92 0.62, 1.4 1.2 0.69, 2.2
44,201-56,000 1.0 0.70, 1.6 1.2 0.64, 2.2
> 56,000 0.83 0.55, 1.3 1.4 0.76, 2.6
NOTE. AOR, adjusted odds ratio; CI, confidence interval; ED, emergency
department; HIV, human immunodeficiency virus; MSM, men who have sex
with men.
*Emergency department visits per 100,000 people.
Table 1 Crude odds ratios for associations between
individual-level and neighborhood-level characteristics
and hospitalizations with CA-MRSA, New York City, 2006
Males Females
OR 95% CI OR 95% CI
Individual
Age (years)
< 18 3.5 2.3, 5.2 4.7 3.1, 6.9
18-44 4.0 3.0, 5.4 1.1 0.75, 1.5
45-64 2.4 1.8, 3.3 1.9 1.4, 2.6
≥ 65 1.0 - 1.0 -
Diabetes
Yes 0.91 0.72, 1.2 1.4 1.1, 1.9
No 1.0 - 1.0 -
HIV
Yes 3.3 2.5, 4.3 3.1 1.9, 5.1
No 1.0 - 1.0 -
Neighborhood
HIV Prevalence
≤ 0.37% 1.0 - 1.0 -
0.38-0.73% 1.2 0.75, 2.0 1.6 0.90, 2.9
0.74%-1.3% 1.6 0.97, 2.7 1.9 1.0, 3.4
1.3-1.65% 1.6 0.98, 2.7 1.2 0.65, 2.4
> 1.65% 1.7 1.0, 2.7 2.7 1.5, 5.0
MSM Proportion
≤ 5.7% 1.0 - 1.0 -
5.8-7.0% 1.4 0.81, 2.3 2.0 1.1, 3.8
7.1-8.0% 1.6 1.0, 2.4 1.6 0.94, 2.8
8.1-9.8% 1.9 1.2, 3.1 2.1 1.1, 3.9
> 9.8% 1.4 0.90, 2.2 1.5 0.84, 2.8
Income per year ($)
≤ 26,000 1.2 0.82, 1.9 1.2 0.70, 2.1
26,001-35,000 0.81 0.51, 1.3 0.64 0.35, 1.2
35,000-41,000 1.30 0.85, 2.1 0.97 0.52, 1.8
41,000-48,000 0.69 0.44, 1.1 0.77 0.44, 1.4
> 48,000 1.0 - 1.0 -
ED Usage Rate*
≤ 24,000 1.0 - 1.0 -
24,001-32,600 0.68 0.42, 1.1 1.0 0.54, 2.0
32,601-44,200 1.1 0.71, 1.6 1.4 0.76, 2.4
44,201-56,000 1.3 0.86, 2.0 1.4 0.77, 2.6
> 56,000 1.2 0.78, 1.8 1.8 0.99, 3.3
NOTE. CI, confidence interval; ED, emergency department; HIV, human
immunodeficiency virus; MSM, men who have sex with men; OR, odds ratio.
* Emergency department visits per 100,000 people.
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In New York City-based analyses, high rates of CA-MRSA
observed among MSM were associated with HIV infection,
crystal methamphetamine use, physical contact with some-
one with a skin infection, sex at private parties, and perhaps
membership in social networks that include others engaged
in these behaviors [13]. Though we were unable to control
for MSM status at the individual-level in our analysis of
males, the finding that neighborhood proportion of MSM
was associated with the risk of CA-MRSA hospitalization
among females is intriguing, and suggests the possibility of
a neighborhood-level effect. Epidemiologic data suggest
that HIV prevalence among MSM in New York City is high
(e.g., 8.8% overall, and 17.7% among MSM in Manhattan)
[29], making it difficult to distinguish between the poten-
tially independent role of each factor. The lack of a dose–
response relationship among males or females, however,
make these results difficult to interpret, and the associ-
ation between neighborhood MSM proportion and CA-
MRSA needs to be evaluated in future research before
stronger conclusions can be drawn.
Epidemiologic studies have shown that neighborhood
factors have independent associations with a number of
health outcomes, including neighborhood socioeconomic
status with diabetes [18] and heart disease [16], and neigh-
borhood poverty with relapse into injecting drug use [17].
Although neighborhood characteristics have commonly
been explored with regard to chronic diseases and health
outcomes, they likely also affect infectious disease risk. The
extent of transmission or acquisition in a given geographic
area is dependent upon a number of relevant factors that
may in fact vary by neighborhood, including the number of
hosts susceptible to infection and the number of hosts
who are currently infected or are carriers of the microbial
agent. Contacts between infectious and susceptible persons
will occur in many settings, including the neighborhood in
which infectious persons reside [30].
Our analysis has limitations that merit discussion. At
the individual level, V-code 09.0 and ICD-9 CM codes
indicating Staphylococcus infection have been used in
published literature to identify MRSA cases in adminis-
trative data [4,31-34] though some analyses have shown
conflicting results as to the accuracy of these definitions
[35,36]. Schweizer, et al. found that use of administrative
coding lacked sensitivity and have low positive predictive
value for hospital-associated infections [35]. A second
study by Schaefer, et al. found low sensitivity, leading to
an underestimation of the number of cases, but high
positive predictive value particularly for community-
associated infections [36]. In addition, lack of laboratory
data and healthcare history may have led to misclassifi-
cation of susceptible versus resistant infection and of
community- versus hospital-associated infection.
It was not possible to apply the Centers for Disease
Control and Prevention’s definition of CA-MRSA to our
dataset [37]; however, study inclusion and exclusion cri-
teria were used as a proxy. Patients could not be linked
across calendar years and therefore examining the full
12 months prior to hospitalization was not possible. This
particularly affects those patients hospitalized early in
2006. Additionally, the definition used in this analysis
likely resulted in exclusion of some CA-MRSA cases
(those with certain chronic diseases also associated with
HA-MRSA) but was necessary to improve the specificity
of our outcome definition. Staphylococcus infections
which were not recorded on the hospital discharge rec-
ord or incorrect diagnosis coding could have resulted in
some misclassification. Specifically, Staphylococcus
infections other than CA-MRSA may have been incor-
rectly classified as CA-MRSA rather than excluded from
analysis. Finally, the primary cause of hospitalization
need not have been CA-MRSA, which may lead to an
overestimation of hospitalizations primarily due to
CA-MRSA.
At the UHF neighborhood level, HIV prevalence, MSM
proportion, and ED usage values may be underestimates
due to lack of diagnosis, reporting, or inaccurate survey
responses and 2000 Census data may not accurately repre-
sent neighborhood income in 2006. Misclassification of
these neighborhood-level covariates was non-differential
by outcome status at the individual-level. Additionally,
neighborhood measures are aggregations of individual-
level information. Variation will exist among individuals
living in a single neighborhood. Finally, there are many
ways to designate “neighborhoods” in geographic analyses,
including UHF, zip code, cities, et cetera and the specific
designations used in our analysis may have affected our
results. Due to small numbers of neighborhoods, we were
unable to control for multiple neighborhood-level factors
in the same model, 7which could result in uncontrolled
confounding at the neighborhood level. We were also
unable to measure individual socioeconomic status and
MSM status and therefore could not control for them
in modeling.
Conclusions
CA-MRSA-associated hospitalizations are relatively com-
mon in New York City and elsewhere, with substantial
geographic variability. Using hospital discharge data, we
were able to examine nearly 1 million hospitalizations in a
population-based analysis, providing an extensive view of
the New York City population. Our combination of this
data with other population-level sources available gave us
a unique opportunity to examine possible neighborhood-
level risk factors for CA-MRSA hospitalizations while
controlling for important individual risk factors. This ana-
lysis suggests that, over and above individual-level risk
factors, CA-MRSA hospitalization may be linked to
neighborhood-level characteristics such as HIV prevalence
Farr et al. BMC Infectious Diseases 2013, 13:84 Page 6 of 8
http://www.biomedcentral.com/1471-2334/13/84
and MSM proportion. It is important to further under-
stand the epidemiology of this infectious disease in order
to initiate prevention strategies targeted to appropriate
populations and risk factors. As many public health
interventions are undertaken at the neighborhood-level, it
is essential to elucidate possible neighborhood-level risk
factors for morbidity. Future research should focus on
examining the impact of neighborhood-level factors
such as HIV prevalence and MSM proportion on the
incidence of CA-MRSA and Staphylococcus aureus
infections, as well as hospitalizations in other cities and
nationally (i.e., over wider geographic areas) and to further
determine the independent role of each of these factors.
Additionally, more focused research studies are needed to
understand the complex nature of the high CA-MRSA
hospitalization rates found in this study in certain
neighborhoods of New York City, such as the Bronx.
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